Harrow (HROW) Common Equity (2010 - 2026)
Harrow (HROW) reported Common Equity of $15.2 million for Q2 2026, down 69.2% from $49.3 million a year earlier and down 46.4% from the prior quarter.
Powered by 
Analysis
Harrow (HROW) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Harrow posted Common Equity of $52.45 million, down 24.3% from FY2024.
- Common Equity has a five-year compound annual growth rate of 14.3% (FY2020 to FY2025).
- By year, Common Equity came in at $69.3 million in FY2024 (-1.6%), $70.41 million in FY2023 (+158.5%), $27.24 million in FY2022 (+149.2%) and $10.93 million in FY2021 (-59.3%).
- The Q2 2026 figure ranks as the lowest quarterly Common Equity since Q3 2022.
- Year over year, Common Equity has now declined in each of the last eight quarters, with an average decline of 26.1% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q2 2023 (growth of 308.8%); the low point was Q3 2022 (a decline of 94.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $28.35 million (Q1 2026), $52.45 million (Q4 2025) and $47.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Harrow | 1.18 Bn | 858.40 Mn | 50.36 Mn | 15.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.20 Mn |
| Mar 31, 2026 | 28.35 Mn |
| Dec 31, 2025 | 52.45 Mn |
| Sep 30, 2025 | 47.02 Mn |
| Jun 30, 2025 | 49.30 Mn |
| Mar 31, 2025 | 56.10 Mn |
| Dec 31, 2024 | 69.30 Mn |
| Sep 30, 2024 | 57.62 Mn |
| Jun 30, 2024 | 58.18 Mn |
| Mar 31, 2024 | 60.21 Mn |
| Dec 31, 2023 | 70.41 Mn |
| Sep 30, 2023 | 75.40 Mn |
| Jun 30, 2023 | 22.05 Mn |
| Mar 31, 2023 | 21.53 Mn |
| Dec 31, 2022 | 27.24 Mn |
| Sep 30, 2022 | 862,000.00 |
| Jun 30, 2022 | 5.39 Mn |
| Mar 31, 2022 | 9.74 Mn |
| Dec 31, 2021 | 10.93 Mn |
| Sep 30, 2021 | 16.23 Mn |
API Access
Harrow Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=HROW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "HROW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=HROW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();